We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$171M
O
2
OrbiMed
New York
$68.2M
RCM
3
RA Capital Management
Massachusetts
$63.7M
NI
4
Nextech Invest
Switzerland
$53.3M +$63.4M +3,008,243 New
VVA
5
Vida Ventures Advisors
Massachusetts
$48.7M
Fidelity Investments
6
Fidelity Investments
Massachusetts
$37.1M -$102K -4,823 -0.2%
BlackRock
7
BlackRock
New York
$36.3M +$3.64M +172,674 +9%
Vanguard Group
8
Vanguard Group
Pennsylvania
$34.1M +$1.28M +60,815 +3%
BC
9
Boxer Capital
California
$32.7M
Viking Global Investors
10
Viking Global Investors
Connecticut
$32.3M
Citadel Advisors
11
Citadel Advisors
Florida
$19.9M -$687K -32,569 -3%
DM
12
Deerfield Management
New York
$17.5M -$906K -42,940 -4%
FCMV
13
Foresite Capital Management V
California
$15.5M
VA
14
VR Adviser
New York
$13.7M -$14.8M -700,000 -48%
N
15
Natixis
France
$11.9M +$14.2M +672,500 New
NHAS
16
Novo Holdings A/S
Denmark
$9.8M +$1.15M +54,600 +11%
HMC
17
Harvard Management Company
Massachusetts
$8.82M
State Street
18
State Street
Massachusetts
$6.89M +$1.19M +56,355 +17%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$6.44M +$557K +26,410 +8%
RSCM
20
Rock Springs Capital Management
Maryland
$6.02M +$145K +6,860 +2%
Federated Hermes
21
Federated Hermes
Pennsylvania
$5.45M
FCOMV
22
Foresite Capital Opportunity Management V
California
$5.17M +$6.15M +291,667 New
PHS
23
PFM Health Sciences
California
$4.68M
WP
24
Woodline Partners
California
$4.61M
American Century Companies
25
American Century Companies
Missouri
$3.79M +$840K +39,855 +23%